Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jeffrey I. Stewart"'
Autor:
Rohit Gupta, Steven D. Nathan, Oksana A. Shlobin, Jeffrey I. Stewart, Robert P. Baughman, Franck Rahaghi, Elyse E. Lower, Joyce Zeigler, Peter J. Engel
Publikováno v:
Chest. 161:448-457
Background Riociguat is effective in delaying the time to clinical worsening (TCW) in patients with groups 1 and 4 pulmonary hypertension. Research Question Is riociguat more effective than placebo in prolonging TCW in sarcoidosis-associated pulmonar
Autor:
Chirantan Mangukia, Shrey Patel, Gengo Sunagawa, F Jaffe, Stacey Brann, Yoshiya Toyoda, Jeffrey I. Stewart
Publikováno v:
Indian Journal of Thoracic and Cardiovascular Surgery
We describe a case of successful use of veno-arterial (VA) extracorporeal membrane oxygenation (ECMO), as a bridge to cytoreductive therapy, in a patient with large mediastinal mass due to T cell lymphoblastic leukemia, complicated by acute cardiores
Autor:
M. Zheng, I. Leopold, Parth Rali, T. Standiford, Ryan Townsend, A. Thomas, Rohit Gupta, Jeffrey I. Stewart, G.J. Criner, R. Patel, Maruti Kumaran
Publikováno v:
TP48. TP048 COVID: ARDS CLINICAL STUDIES.
Rationale: The novel coronavirus disease-19 (COVID-19) has presented major challenges for global health systems. Given limited availability of diagnostic testing and delays in test results during the first wave of the pandemic, our hospital used comp
Autor:
Jeffrey I. Stewart, G.J. Criner, Huaqing Zhao, A. Thomas, I. Leopold, Rohit Gupta, Ryan Townsend, M. Zheng, Parth Rali, T. Standiford, Maruti Kumaran, R. Patel
Publikováno v:
TP48. TP048 COVID: ARDS CLINICAL STUDIES.
Rationale: The novel coronavirus disease-19 (COVID-19) has overwhelmed global healthcare systems. It would be beneficial to identify clinical signs that predict adverse outcomes to anticipate clinical deterioration and optimize management. COVID-19 h
Autor:
Yaniv Dotan, Jeffrey I. Stewart, A.J. Mamary, Amandeep Aneja, He Wang, Chandra Dass, A.J. Gangemi, Francis Cordova, Nathaniel Marchetti, Gerard J. Criner, Gilbert E. D'Alonzo, Bhaidharbi Chakraborty, Huaqing Zhao
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BackgroundPulmonary hypertension (PH) causes increased morbidity and mortality in patients with interstitial lung diseases (ILD). Classification schemes, while well-characterised for the vasculopathy of idiopathic PH, have been applied, unchallenged,
Autor:
Jeffrey I. Stewart, G.J. Criner, A.J. Gangemi, He Wang, A.J. Mamary, B. Chakraborty, Amandeep Aneja, Chandra Dass, Yaniv Dotan, N. Marchetti
Publikováno v:
C52. USE YOUR ILLUSION II: CLINICAL RESEARCH IN PAH.
Autor:
Jeffrey I. Stewart, Gerard J. Criner
Publikováno v:
Current Opinion in Pulmonary Medicine. 19:109-115
Chronic obstructive pulmonary disease (COPD) is caused by a mixture of small airway disease (obstructive bronchitis) and parenchymal lung tissue destruction (emphysema). The relative contributions of these two pathologic states vary from person to pe
Autor:
Jeffrey I. Stewart, Sarah Moyle, Gerard J. Criner, Carla Wilson, Ron Tanner, Russell P. Bowler, James D. Crapo, Robert K. Zeldin, Barry J. Make, Elizabeth A. Regan, null for the COPDGene Investigators
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 9:466-472
It can be challenging to maintain longitudinal follow-up of subjects in clinical studies. COPDGene is a multicenter, observational study designed to identify genetic factors associated with COPD and to characterize COPD-related phenotypes. To obtain
Autor:
Gilbert E. D'Alonzo, Heather Clauss, Namrata Patel, David Ciccolella, Jeffrey I. Stewart, Heba Y Durra Md
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 16(1)
Without proper treatment, the mortality of pulmonary mucormycosis is nearly 100%. Although the diagnosis is often made histologically, it can be suspected when patients have a reverse halo sign on computed tomography (CT) of the chest, along with the
Autor:
Jeffrey I. Stewart, Gerard J. Criner, Robert Steiner, Barry J. Make, James Crapo, Edwin K. Silverman, ` and the COPDGene Investigators
Publikováno v:
D105. COPD: PHENOTYPES AND OUTCOMES.